MOLECULAR SCREENING FOR HEPATITIS VIRUS

HBV can cause acute and chronic infection. There is currently no role for molecular testing in the diagnosis of acute hepatitis B other than in the detection of asymptomatic patients during pretransfusion screening of blood products. To facilitate an understanding of the utility of molecular testing for chronic hepatitis B, the four stages of chronic hepatitis B infection that are currently recognized, as well as an additional entity, occult hepatitis B, that can be diagnosed only by sensitive nucleic acid amplification methods, are reviewed in detail, including available therapeutic age.

 


  • Serological and molecular testing
  • Laboratory methods for Diagnosis & management
  • Current molecular metho

Related Conference of MOLECULAR SCREENING FOR HEPATITIS VIRUS

May 21-22, 2026

17th International Conference on Liver Diseases & Hepatology

Aix-en-Provence, France
June 18-19, 2026

9th International Congress on Viral Hepatitis

Paris, France
June 29-30, 2026

5th International Conference on Gastroenterology and Liver

Aix-en-Provence, France
August 03-04, 2026

21st Euro-Global Gastroenterology Conference

London, UK
September 29-30, 2026

7th Global Summit on Earth Science and Climate Change

Aix-en-Provence, France

MOLECULAR SCREENING FOR HEPATITIS VIRUS Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in